Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cadence Molecular Sciences, formerly known as OpenEye Scientific, is a business unit of Cadence Design Systems specializing in computational molecular design and simulation software. The company provides a comprehensive suite of physics-based and AI-driven tools, including its flagship cloud-native SaaS platform, Orion, which enables massive-scale virtual screening and molecular dynamics. Its technology is utilized by 19 of the top 20 global pharmaceutical companies, such as Pfizer and AstraZeneca, to accelerate the discovery and optimization of therapeutic candidates. Headquartered in Santa Fe, New Mexico, the unit combines OpenEye's domain expertise in cheminformatics with Cadence's advanced algorithmic and cloud computing capabilities. Cadence Molecular Sciences serves as a critical partner for the life sciences industry, offering scalable solutions for drug discovery across various modalities including small molecules and antibodies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cadence Molecular Sciences.